HEARTBEAM, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
HEARTBEAM, INC. (BEAT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $1.54 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-31 was $1.61, a 33.20% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.41, a 31.69% increase year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.83.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $1.82, a 24.48% decline from fiscal 2024.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $2.41, a 2.82% decline from fiscal 2023.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $2.48, a 16.78% decline from fiscal 2022.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $2.98, a 4157.14% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.54 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $1.82 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $1.62 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $1.54 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $1.61 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $2.41 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $3.54 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $2.41 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $2.41 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $2.48 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $1.19 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.70 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $1.83 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $2.98 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $3.19 10-Q · filed 2022-11-10 | |||
| 2021-12-31 | $0.07 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.07 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |